`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`C.A. No. 18-1363-CFC
`
`JURY TRIAL DEMANDED
`
`)))))))))
`
`GENENTECH, INC., AND CITY OF HOPE,
`
`Plaintiffs,
`
`v.
`
`SAMSUNG BIOEPIS CO., LTD.,
`
`Defendant.
`
`DEFENDANT SAMSUNG BIOEPIS CO., LTD.’S
`RULE 7.1 CORPORATE DISCLOSURE STATEMENT
`
`Pursuant to Rule 7.1(a) of the Federal Rules of Civil Procedure, Defendant Samsung
`
`Bioepis Co., Ltd., by and through its attorneys, hereby makes the following disclosures:
`
`Samsung BioLogics Co., Ltd. owns 10% or more of Samsung Bioepis Co., Ltd. Samsung
`
`BioLogics Co., Ltd. is owned by Samsung Electronics Co., Ltd. and Samsung C&T.
`
`OF COUNSEL:
`
`Dimitrios T. Drivas
`Scott T. Weingaertner
`Amit H. Thakore
`Holly Tao
`WHITE & CASE LLP
`1221 Avenue of the Americas
`New York, New York 10020-1095
`Tel: (212) 819-8200
`
`Respectfully submitted,
`
`POTTER ANDERSON & CORROON LLP
`
`By: /s/ Bindu A. Palapura
`David E. Moore (#3983)
`Bindu A. Palapura (#5370)
`Stephanie E. O’Byrne (#4446)
`Jennifer Penberthy Buckley (#6264)
`Hercules Plaza, 6th Floor
`1313 N. Market Street
`Wilmington, DE 19801
`Tel: (302) 984-6000
`dmoore@potteranderson.com
`bpalapura@potteranderson.com
`sobyrne@potteranderson.com
`
`Dated: September 27, 2018
`5941637 / 45001
`
`Attorneys for Defendant Samsung Bioepis Co.,
`Ltd.
`
`